“…Some of the temporal steps described by Trivedi et al (2014) (see Figure 5 of Trivedi et al, 2014 ) and others ( Lin et al, 2001 ; Ikemoto et al, 2002 ; Mao et al, 2002 ; Xu et al, 2003 ; Xu et al, 2006 ; Christie, 2008 ; Yang et al, 2008 ; Wang et al, 2009 ; Daijo et al, 2011 ; Gutowicz et al, 2011 ; Liu et al, 2011 ; Maze and Nestler, 2011 ; Lim et al, 2012 ; Sun et al, 2012 ; Browne et al, 2020 ) are as follows: 1) morphine blockade of L-cysteine uptake into neurons by G protein-dependent inhibition of EAA3 activity, 2) resulting decreases in intracellular levels of L-cysteine, L-glutathione, and the methylation index, namely, S-adenosyl-methionine/S-adenosyl-homocysteine (SAM/SAH ratio), 3) decreases in the methylation status of global CpG (regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide in the linear sequence of bases along its 5′ → 3′ direction) and in CpG methylation of long interspersed nuclear element-1 (LINE-1) retrotransposon regulatory regions, and 4) activation of transcription of previously silenced LINE-1 genes. Thus, we hypothesized that co-administration of cell-permeant versions of L-cysteine, such as L-cysteine ethyl ester (L-CYSee) ( Goto et al, 1983 ; Hisadome et al, 1986a ; Hisadome et al, 1986b ; Hisadome et al, 1988 ; Servin et al, 1988 ; Hisadome et al, 1990 ; Schöneich et al, 1992 ; Hobbs et al, 1993 ; Fukui et al, 1994 ; Ding and Demple, 1998 ; Galanakis et al, 2004 ; Mosier-Boss and Lieberman, 2005 ; Perissinotti et al, 2005 ; Defonsi Lestard et al, 2013 ; Mendoza et al, 2013 ; Arias et al, 2019 ), may prevent the acquisition of physical dependence on morphine and reverse established dependence on the opioid. Previously, we reported that L-CYSee ( Lewis et al, 2022 ), L-cysteine methyl ester ( Getsy et al, 2022a ), and other thiolesters and related compounds ( Baby et al, 2021 ; Baby et al, 2021 ; Gaston et al, 2021 ; Jenkins et al, 2021 ; Getsy et al, 2022b ; Getsy et al, 2022c ; Getsy et al, 2022d ;…”